While lentivirus-based shRNA silencing of IGFBP2 decreased activation of ERK and AKT in human leukemia cells [35], it resulted in the inability of p53 to inhibit IGF1-induced ERK phosphorylation in PC-3 cells [59]. This evidence concerns the gene IGFBP2 and leukemia.